Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Ekso Bionics's peak revenue was $18.3M in 2023. The peak quarterly revenue was $8.5M in 2016(q1).
Ekso Bionics's revenue increased from $2.7m in 2012 to $17.9M currently. That's a 562.42% change in annual revenue.
| Fiscal year / year | Ekso Bionics revenue |
|---|---|
| 2012 | $2.7M |
| 2013 | $3.3M |
| 2014 | $5.3M |
| 2015 | $8.7M |
| 2016 | $14.2M |
| 2017 | $7.4M |
| 2018 | $11.3M |
| 2019 | $13.9M |
| 2020 | $8.9M |
| 2021 | $11.2M |
| 2022 | $12.9M |
| 2023 | $18.3M |
| 2024 | $17.9M |
How accurately did Ekso Bionics' revenue projections match actual performance?
Ekso Bionics saw the greatest revenue growth in 2016, when revenue increased by 64.2%.
Ekso Bionics had the lowest revenue growth in 2017, when revenue changed by -48.29%.
| Year | Ekso Bionics growth |
|---|---|
| 2013 | 22%↑ |
| 2014 | 61%↑ |
| 2015 | 63%↑ |
| 2016 | 64%↑ |
| 2017 | -48%↓ |
| 2018 | 54%↑ |
| 2019 | 23%↑ |
| 2020 | -36%↓ |
| 2021 | 27%↑ |
| 2022 | 15%↑ |
| 2023 | 42%↑ |
| 2024 | -2%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | $1.1M | $1.2M | $1.6M | $1.5M |
| 2015 | $1.7M | $2.1M | $2.9M | $1.9M |
| 2016 | $8.5M | $1.6M | $1.6M | $2.6M |
| 2017 | $1.4M | $1.9M | $1.6M | $2.5M |
| 2018 | $2.5M | $3.0M | $2.6M | $3.3M |
| 2019 | $3.6M | $3.3M | $3.3M | $3.7M |
| 2020 | $1.5M | $2.3M | $2.9M | $2.3M |
| 2021 | $1.9M | $2.2M | $3.0M | $4.1M |
| 2022 | $2.6M | $3.5M | $3.3M | $3.6M |
| 2023 | $4.1M | $4.7M | $4.6M | $4.8M |
| 2024 | $3.8M | $5.0M | $4.1M | $5.1M |
Do you work at Ekso Bionics?
Did Ekso Bionics meet its revenue projections?
| CEO | Steven Sherman |
| Industry | Commercial & Professional Services |
| Company Type | Public |
| Employees Number | 77 |
| Date Founded | 2005 |
| Headquarters | Richmond, California |
| Number of Locations | 4 |
| Revenue | $17.9M |
| Net Income | -$15,080,000 |
| Gross Proft | $9.5M (2024) |
| PE Ratio | -2.46 |
| Market Capitalization | $27.9M |
| Total Assets | $40,903,000 |
| Ticker | EKSO |
Ekso Bionics received early financing of $9.1M on 2012-06-21.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $9M | 06/2012 |
| Debt Financing | $5M | 12/2013 |
| Post Ipo Equity | $30.3M | 02/2014 |
| Post Ipo Equity | $22.8M | 12/2014 |
| Post Ipo Equity | $13.7M | 08/2016 |
| Post Ipo Debt | $10M | 01/2017 |
| Post Ipo Equity | $34M | 09/2017 |
| Post Ipo Equity | $10M | 05/2019 |
| Post Ipo Equity | $5M | 12/2019 |
| Post Ipo Equity | $7.9M | 06/2020 |
| Post Ipo Equity | $40M | 02/2021 |
| Investors | Security type |
|---|---|
| Opaleye Management | Post Ipo Equity |
| Montrose Capital Partners | Post Ipo Equity |
| Bridge Bank | Post Ipo Debt |
Ekso Bionics's top competitor, Alphabet, earned an annual revenue of $350.0B.
Ekso Bionics's smallest competitor is Air Techniques with revenue of $1.5M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| DEKA Research | $63,177 | $46.3M | 200 | 58 |
| General Electric | $86,183 | $68.0B | 305,000 | 3,685 |
| Nuance Communications | $88,401 | $1.4B | 6,501 | - |
| IBM | $86,845 | $62.8B | 270,000 | 3,027 |
| Xerox | $40,954 | $6.2B | 24,700 | 681 |
| Alphabet | $58,794 | $350.0B | 156,301 | 5 |
| Lyft | $67,087 | $5.8B | 4,369 | 361 |
| Air Techniques | $44,883 | $1.5M | 15 | 5 |
Zippia gives an in-depth look into the details of Ekso Bionics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ekso Bionics. The employee data is based on information from people who have self-reported their past or current employments at Ekso Bionics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ekso Bionics. The data presented on this page does not represent the view of Ekso Bionics and its employees or that of Zippia.
Ekso Bionics may also be known as or be related to EKSO BIONICS HOLDINGS, INC., Ekso Bionics, Ekso Bionics Europe GmbH, Ekso Bionics Holdings Inc, Ekso Bionics Holdings Inc., Ekso Bionics Holdings, Inc. and Ekso Bionics, Inc.